Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 806-812

  Maguire, Janet J ^a   Wiley, Katherine E ^a   Kuc, Rhoda E ^a   Stoneman, Victoria E A ^a   Bennett, Martin R ^a   Davenport, Anthony P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

ApoE mouse; Atherosclerosis; Atorvastatin; Endothelin 1; Vasoconstriction

Indexed keywords

APOLIPOPROTEIN E; ATORVASTATIN; ENDOTHELIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; STATIN;

ANIMAL MODEL; ATHEROSCLEROSIS; BINDING ASSAY; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; DISEASE COURSE; HISTOPATHOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; RECEPTOR AFFINITY; VASOCONSTRICTION;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ENDOTHELINS; FEMALE; HEPTANOIC ACIDS; HOMOZYGOTE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PYRROLES; TIME FACTORS; VASOCONSTRICTION;

ANIMALIA;

EID: 33744911354     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg S. Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325:997-1001, 1991.
2. Bacon CR, Cary NRB, Davenport AP. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res 79:794-801, 1996.
3. Maguire JJ, Davenport AP. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for upregulation of endothelin-converting enzyme activity in disease. Br J Pharmacol 125:238-240, 1998.
4. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471, 1992.
5. Kobayashi T, Miyauchi T, Iwasa S, Fan J, Nagat M, Goto K, Watanabe T. Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis. Pathol Int 50:929-936, 2000.
6. Braganza D, Stoneman V, Figg N, Bennett M. Atorvastatin alters plaque composition in ApoE knockout mice independent of lipid lowering. Heart 89:A46, 2003.
7. Grothusen C, Bley S, Selle T, Luchtefeld M, Grote K, Tietge WJF, Drexler H, Schieffer B. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis. Atherosclerosis 182:57-69, 2005.
8. Davenport AP, Kuc RE. Radioligand-binding and molecular-imaging techniques for the quantitative analysis of established and emerging orphan receptor systems. Methods Mol Biol 306:93-120, 2005.
9. Pierre LN, Davenport AP. Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br J Pharmacol 1124:499-506, 1998.
10. A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 95:14367-14372, 1998.
11. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide 5:88-97, 2001.
12. Giardina JB, Tanner DJ, Khali RA. Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon. Hypertension 37:561-568, 2001.
13. Bolz SS, Galle J, Derwand R, de Wit C, Pohl U. Oxidized LDL increases the sensitivity of the contractile apparatus in isolated resistance arteries for Ca(2+) via a rho- and rho kinase-dependent mechanism. Circulation 102:2402-2410, 2000.
14. Buyukafsar K, Arikan O, Ark M, Kubat H, Ozveren E. Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats. Eur J Pharmacol 498:211-217, 2004.
15. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101:2711-2719, 1998.
16. Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 23:729-736, 2003.
17. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712-1719, 2001.
18. Batchelor TJ, Sadaba JR, Ishola A, Pacaud P, Munsch CM, Beech DJ. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol 132:302-308, 2001.
19. Mraiche F, Cena J, Das D, Vollrath B. Effects of statins on vascular function of endothelin-1. Br J Pharmacol 144:715-726, 2005.